Nicholas A Van Lith, MD | |
3300 Providence Dr Ste B314, Anchorage, AK 99508-4621 | |
(907) 212-3420 | |
(907) 212-3429 |
Full Name | Nicholas A Van Lith |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 9 Years |
Location | 3300 Providence Dr Ste B314, Anchorage, Alaska |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1720466949 | NPI | - | NPPES |
1630677 | Medicaid | AK |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 100987 (Alaska) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Providence Alaska Medical Center | Anchorage, AK | Hospital |
Alaska Regional Hospital | Anchorage, AK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Providence Health And Services- Washington | 1557408176 | 143 |
Select Physical Therapy Holdings Inc | 9537076401 | 1487 |
News Archive
WebMD Health Corp. announced today that it is increasing the price in the pending tender offer for its common stock to $46.80 per share. The number of shares proposed to be purchased in the tender offer is, as previously announced, 5,800,000, representing approximately 11% of WebMD's currently outstanding shares.
Eighteen years later, people who worked with lead have significant loss of brain cells and damage to brain tissue, according to a new study published in the May 23, 2006, issue of Neurology, the scientific journal of the American Academy of Neurology.
Scientists have been trying for years now to understand what causes overweight and obesity in some but not in others. Now researchers at the Monash University's Biomedicine Discovery Institute seem to have solved the puzzle that has been baffling them all – a so called "fat switch" in the brain that regulates weight gain. This could also mean a new potential for treatment of obesity in future. The study appeared in the journal Cell Metabolism today.
According to a new ‘State of Our Public Hospitals' report there is a 17 percent hike in the number of people seeking treatment at Australian hospitals in the last five years. This report was released by Health Minister Nicola Roxon on Tuesday.
Serono and IVAX Corporation has announced positive results from two clinical trials with a new proprietary oral formulation of cladribine, a potential new treatment for multiple sclerosis (MS). The study results showed that the formulation of oral cladribine which has been developed by Serono and IVAX has met the targets for an orally administered product, with blood levels of cladribine in the expected therapeutic range. Efficacy studies of oral cladribine in MS patients are planned to start late 2004.
› Verified 5 days ago
Entity Name | Providence Health & Services- Washington |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093956278 PECOS PAC ID: 1557408176 Enrollment ID: O20091029000679 |
News Archive
WebMD Health Corp. announced today that it is increasing the price in the pending tender offer for its common stock to $46.80 per share. The number of shares proposed to be purchased in the tender offer is, as previously announced, 5,800,000, representing approximately 11% of WebMD's currently outstanding shares.
Eighteen years later, people who worked with lead have significant loss of brain cells and damage to brain tissue, according to a new study published in the May 23, 2006, issue of Neurology, the scientific journal of the American Academy of Neurology.
Scientists have been trying for years now to understand what causes overweight and obesity in some but not in others. Now researchers at the Monash University's Biomedicine Discovery Institute seem to have solved the puzzle that has been baffling them all – a so called "fat switch" in the brain that regulates weight gain. This could also mean a new potential for treatment of obesity in future. The study appeared in the journal Cell Metabolism today.
According to a new ‘State of Our Public Hospitals' report there is a 17 percent hike in the number of people seeking treatment at Australian hospitals in the last five years. This report was released by Health Minister Nicola Roxon on Tuesday.
Serono and IVAX Corporation has announced positive results from two clinical trials with a new proprietary oral formulation of cladribine, a potential new treatment for multiple sclerosis (MS). The study results showed that the formulation of oral cladribine which has been developed by Serono and IVAX has met the targets for an orally administered product, with blood levels of cladribine in the expected therapeutic range. Efficacy studies of oral cladribine in MS patients are planned to start late 2004.
› Verified 5 days ago
Entity Name | Neuroversion |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1487102208 PECOS PAC ID: 7012297062 Enrollment ID: O20161208000642 |
News Archive
WebMD Health Corp. announced today that it is increasing the price in the pending tender offer for its common stock to $46.80 per share. The number of shares proposed to be purchased in the tender offer is, as previously announced, 5,800,000, representing approximately 11% of WebMD's currently outstanding shares.
Eighteen years later, people who worked with lead have significant loss of brain cells and damage to brain tissue, according to a new study published in the May 23, 2006, issue of Neurology, the scientific journal of the American Academy of Neurology.
Scientists have been trying for years now to understand what causes overweight and obesity in some but not in others. Now researchers at the Monash University's Biomedicine Discovery Institute seem to have solved the puzzle that has been baffling them all – a so called "fat switch" in the brain that regulates weight gain. This could also mean a new potential for treatment of obesity in future. The study appeared in the journal Cell Metabolism today.
According to a new ‘State of Our Public Hospitals' report there is a 17 percent hike in the number of people seeking treatment at Australian hospitals in the last five years. This report was released by Health Minister Nicola Roxon on Tuesday.
Serono and IVAX Corporation has announced positive results from two clinical trials with a new proprietary oral formulation of cladribine, a potential new treatment for multiple sclerosis (MS). The study results showed that the formulation of oral cladribine which has been developed by Serono and IVAX has met the targets for an orally administered product, with blood levels of cladribine in the expected therapeutic range. Efficacy studies of oral cladribine in MS patients are planned to start late 2004.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Nicholas A Van Lith, MD Po Box 4105, Portland, OR 97208-4105 Ph: (866) 907-1068 | Nicholas A Van Lith, MD 3300 Providence Dr Ste B314, Anchorage, AK 99508-4621 Ph: (907) 212-3420 |
News Archive
WebMD Health Corp. announced today that it is increasing the price in the pending tender offer for its common stock to $46.80 per share. The number of shares proposed to be purchased in the tender offer is, as previously announced, 5,800,000, representing approximately 11% of WebMD's currently outstanding shares.
Eighteen years later, people who worked with lead have significant loss of brain cells and damage to brain tissue, according to a new study published in the May 23, 2006, issue of Neurology, the scientific journal of the American Academy of Neurology.
Scientists have been trying for years now to understand what causes overweight and obesity in some but not in others. Now researchers at the Monash University's Biomedicine Discovery Institute seem to have solved the puzzle that has been baffling them all – a so called "fat switch" in the brain that regulates weight gain. This could also mean a new potential for treatment of obesity in future. The study appeared in the journal Cell Metabolism today.
According to a new ‘State of Our Public Hospitals' report there is a 17 percent hike in the number of people seeking treatment at Australian hospitals in the last five years. This report was released by Health Minister Nicola Roxon on Tuesday.
Serono and IVAX Corporation has announced positive results from two clinical trials with a new proprietary oral formulation of cladribine, a potential new treatment for multiple sclerosis (MS). The study results showed that the formulation of oral cladribine which has been developed by Serono and IVAX has met the targets for an orally administered product, with blood levels of cladribine in the expected therapeutic range. Efficacy studies of oral cladribine in MS patients are planned to start late 2004.
› Verified 5 days ago
Candace L Clawson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-1624 Fax: 907-729-1634 | |
Dr. William Murray Buttner, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 E 36th Ave, Anchorage, AK 99508 Phone: 907-562-9229 Fax: 907-561-4806 | |
Robert L Mcalister, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 E 36th Ave, Anchorage, AK 99508 Phone: 907-562-2992 | |
Shane W Cummings, M D Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1310 E Dimond Blvd, Suite 1, Anchorage, AK 99515 Phone: 907-344-2400 Fax: 907-344-2404 | |
Jeremy D Wood, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 910 Compassion Cir, Anchorage, AK 99504 Phone: 907-212-9200 Fax: 907-212-9283 | |
Kelton Hillard Oliver, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 12302 Woodward Dr, Anchorage, AK 99516 Phone: 907-580-0002 | |
Ryan T. Mcwilliams, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4320 Diplomacy Dr, Suite 1191, Anchorage, AK 99508 Phone: 907-729-6321 |